{"transactions":[{"id":693552,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-08-07T22:01:08.000Z","date":"2026-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":780,"price":261.62,"value":204063.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":47131,"source":{"system":"sec-edgar","filing":"0001805688-26-000014","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000014/edgardoc.xml","form_type":"4"}},{"id":719587,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-07-02T22:27:58.000Z","date":"2026-06-30","kind":"tax_withholding","planned":false,"acquired":false,"shares":2527,"price":237.72,"value":600718.44,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 29, 2026."}],"balance_after":47911,"source":{"system":"sec-edgar","filing":"0001805688-26-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000012/edgardoc.xml","form_type":"4"}},{"id":757887,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2026-06-01T20:06:22.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":false,"shares":6907,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vested in 36 equal monthly installments thereafter. The option was fully vested as of March 2, 2024."}],"balance_after":0,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":6907},"source":{"system":"sec-edgar","filing":"0001805688-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000008/edgardoc.xml","form_type":"4"}},{"id":757886,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:06:22.000Z","date":"2026-05-28","kind":"sale","planned":false,"acquired":false,"shares":6907,"price":235.41,"value":1625976.87,"ownership":{"direct":true},"balance_after":50272,"source":{"system":"sec-edgar","filing":"0001805688-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000008/edgardoc.xml","form_type":"4"}},{"id":757885,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-06-01T20:06:22.000Z","date":"2026-05-28","kind":"exercise","planned":false,"acquired":true,"shares":6907,"price":109.45,"value":755971.15,"ownership":{"direct":true},"balance_after":57179,"source":{"system":"sec-edgar","filing":"0001805688-26-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000008/edgardoc.xml","form_type":"4"}},{"id":854722,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-09T21:23:15.000Z","date":"2026-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2503,"price":188.69,"value":472291.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":50272,"source":{"system":"sec-edgar","filing":"0001805688-26-000006","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000006/edgardoc.xml","form_type":"4"}},{"id":875462,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-03-02T22:19:00.000Z","date":"2026-02-26","kind":"grant","planned":false,"acquired":true,"shares":9782,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2026, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":52775,"source":{"system":"sec-edgar","filing":"0001805688-26-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000004/edgardoc.xml","form_type":"4"}},{"id":934697,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T01:17:40.000Z","date":"2026-01-16","kind":"tax_withholding","planned":false,"acquired":false,"shares":1599,"price":171.16,"value":273684.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares withheld from the vesting and distribution of performance share awards to satisfy the reporting person's tax obligations."}],"balance_after":42993,"source":{"system":"sec-edgar","filing":"0001805688-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000002/edgardoc.xml","form_type":"4"}},{"id":934696,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2026-01-22T01:17:40.000Z","date":"2026-01-16","kind":"grant","planned":false,"acquired":true,"shares":3637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of the Issuer delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2023. The performance-based vesting requirements applicable to such awards were satisfied on January 16, 2026, which represents the date on which the level of performance\nattained was certified."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 140 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 28, 2025."}],"balance_after":44592,"source":{"system":"sec-edgar","filing":"0001805688-26-000002","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568826000002/edgardoc.xml","form_type":"4"}},{"id":1072655,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2025-08-07T22:06:29.000Z","date":"2025-08-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":577,"price":116.1,"value":66989.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025."}],"balance_after":40815,"source":{"system":"sec-edgar","filing":"0001765581-25-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558125000051/edgardoc.xml","form_type":"4"}},{"id":1218361,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-08T00:00:44.000Z","date":"2025-03-05","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":1905,"price":138.95,"value":264699.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":41226,"source":{"system":"sec-edgar","filing":"0001765581-25-000029","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558125000029/edgardoc.xml","form_type":"4"}},{"id":1237126,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:35:45.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":5778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026."}],"balance_after":43131,"source":{"system":"sec-edgar","filing":"0001765581-25-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558125000016/edgardoc.xml","form_type":"4"}},{"id":1237125,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2025-03-04T00:35:45.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":11941,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":37353,"source":{"system":"sec-edgar","filing":"0001765581-25-000016","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558125000016/edgardoc.xml","form_type":"4"}},{"id":1298248,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:40:34.000Z","date":"2025-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1365,"price":122.62,"value":167376.3,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations."}],"balance_after":25412,"source":{"system":"sec-edgar","filing":"0001805688-25-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568825000003/edgardoc.xml","form_type":"4"}},{"id":1298247,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2025-01-22T23:40:34.000Z","date":"2025-01-17","kind":"grant","planned":false,"acquired":true,"shares":2533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024."}],"balance_after":26777,"source":{"system":"sec-edgar","filing":"0001805688-25-000003","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000180568825000003/edgardoc.xml","form_type":"4"}},{"id":1439923,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Commercial Officer"}}],"security":"Ordinary Shares","published_at":"2024-08-06T20:53:52.000Z","date":"2024-08-02","kind":"grant","planned":false,"acquired":true,"shares":6996,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of August 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 160 ordinary shares acquired on May 31, 2024 under a Section 423 Employee Stock Purchase Plan."}],"balance_after":24078,"source":{"system":"sec-edgar","filing":"0001765581-24-000072","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558124000072/edgardoc.xml","form_type":"4"}},{"id":1590017,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2024-03-08T02:49:18.000Z","date":"2024-03-05","kind":"tax_withholding","planned":false,"acquired":false,"shares":2474,"price":117.53,"value":290769.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":16922,"source":{"system":"sec-edgar","filing":"0001765581-24-000035","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558124000035/edgardoc.xml","form_type":"4"}},{"id":1599567,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2024-03-06T00:52:12.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":5065,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2024, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":19396,"source":{"system":"sec-edgar","filing":"0001765581-24-000022","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558124000022/edgardoc.xml","form_type":"4"}},{"id":1675799,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:33:36.000Z","date":"2024-01-17","kind":"tax_withholding","planned":false,"acquired":false,"shares":1038,"price":119.13,"value":123656.94,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations."}],"balance_after":14331,"source":{"system":"sec-edgar","filing":"0001784606-24-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000178460624000012/edgardoc.xml","form_type":"4"}},{"id":1675798,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2024-01-19T23:33:36.000Z","date":"2024-01-17","kind":"grant","planned":false,"acquired":true,"shares":2210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on May 5, 2021. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2024, which represents the date on which the level of performance attained was certified."}],"balance_after":15369,"source":{"system":"sec-edgar","filing":"0001784606-24-000012","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000178460624000012/edgardoc.xml","form_type":"4"}},{"id":1967093,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:54:40.000Z","date":"2023-03-05","kind":"tax_withholding","acquired":false,"shares":2020,"price":142.78,"value":288415.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":13159,"source":{"system":"sec-edgar","filing":"0001765581-23-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000019/edgardoc.xml","form_type":"4"}},{"id":1967092,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2023-03-08T01:54:40.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":3870,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2023, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":15179,"source":{"system":"sec-edgar","filing":"0001765581-23-000019","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000019/edgardoc.xml","form_type":"4"}},{"id":2031156,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-02-06T21:26:06.000Z","date":"2023-02-02","kind":"exercise","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":6907,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001765581-23-000008","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000008/edgardoc.xml","form_type":"4"}},{"id":2031155,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2023-02-06T21:26:06.000Z","date":"2023-02-02","kind":"sale","acquired":false,"shares":531,"price":157.26,"value":83505.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-23-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000008/edgardoc.xml","form_type":"4"}},{"id":2031154,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2023-02-06T21:26:06.000Z","date":"2023-02-02","kind":"exercise","acquired":true,"shares":531,"price":109.45,"value":58117.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11840,"source":{"system":"sec-edgar","filing":"0001765581-23-000008","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000008/edgardoc.xml","form_type":"4"}},{"id":2064075,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-01-05T23:43:39.000Z","date":"2023-01-03","kind":"exercise","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":7438,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001765581-23-000004","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000004/edgardoc.xml","form_type":"4"}},{"id":2064074,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:43:39.000Z","date":"2023-01-03","kind":"sale","acquired":false,"shares":531,"price":159.59,"value":84742.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-23-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000004/edgardoc.xml","form_type":"4"}},{"id":2064073,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2023-01-05T23:43:39.000Z","date":"2023-01-03","kind":"exercise","acquired":true,"shares":531,"price":109.45,"value":58117.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11840,"source":{"system":"sec-edgar","filing":"0001765581-23-000004","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558123000004/edgardoc.xml","form_type":"4"}},{"id":2085656,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-12-15T23:29:47.000Z","date":"2022-12-13","kind":"exercise","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":7969,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001765581-22-000140","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000140/edgardoc.xml","form_type":"4"}},{"id":2085655,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-12-15T23:29:47.000Z","date":"2022-12-13","kind":"sale","acquired":false,"shares":531,"price":155.45,"value":82543.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000140/edgardoc.xml","form_type":"4"}},{"id":2085654,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-12-15T23:29:47.000Z","date":"2022-12-13","kind":"exercise","acquired":true,"shares":531,"price":109.45,"value":58117.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11840,"source":{"system":"sec-edgar","filing":"0001765581-22-000140","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000140/edgardoc.xml","form_type":"4"}},{"id":2118948,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-14T23:16:10.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":8500,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001765581-22-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000120/edgardoc.xml","form_type":"4"}},{"id":2118947,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-11-14T23:16:10.000Z","date":"2022-11-10","kind":"exercise","acquired":false,"shares":532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":9031,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":532},"source":{"system":"sec-edgar","filing":"0001765581-22-000120","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000120/edgardoc.xml","form_type":"4"}},{"id":2118946,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-11-14T23:16:10.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":531,"price":155,"value":82305.0,"ownership":{"direct":true},"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000120/edgardoc.xml","form_type":"4"}},{"id":2118945,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-11-14T23:16:10.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":531,"price":109.45,"value":58117.95,"ownership":{"direct":true},"balance_after":11840,"source":{"system":"sec-edgar","filing":"0001765581-22-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000120/edgardoc.xml","form_type":"4"}},{"id":2118944,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-11-14T23:16:10.000Z","date":"2022-11-10","kind":"sale","acquired":false,"shares":532,"price":155,"value":82460.0,"ownership":{"direct":true},"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000120/edgardoc.xml","form_type":"4"}},{"id":2118943,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-11-14T23:16:10.000Z","date":"2022-11-10","kind":"exercise","acquired":true,"shares":532,"price":109.45,"value":58227.4,"ownership":{"direct":true},"balance_after":11841,"source":{"system":"sec-edgar","filing":"0001765581-22-000120","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000120/edgardoc.xml","form_type":"4"}},{"id":2164613,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-09-07T21:12:59.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":9563,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001765581-22-000109","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000109/edgardoc.xml","form_type":"4"}},{"id":2164612,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-09-07T21:12:59.000Z","date":"2022-09-02","kind":"sale","acquired":false,"shares":531,"price":156.98,"value":83356.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000109/edgardoc.xml","form_type":"4"}},{"id":2164611,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-09-07T21:12:59.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":531,"price":109.45,"value":58117.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11840,"source":{"system":"sec-edgar","filing":"0001765581-22-000109","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000109/edgardoc.xml","form_type":"4"}},{"id":2192264,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-08-08T20:33:22.000Z","date":"2022-08-04","kind":"exercise","acquired":false,"shares":531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":10094,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":531},"source":{"system":"sec-edgar","filing":"0001765581-22-000075","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000075/edgardoc.xml","form_type":"4"}},{"id":2192263,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-08-08T20:33:22.000Z","date":"2022-08-04","kind":"sale","acquired":false,"shares":531,"price":155,"value":82305.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000075","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000075/edgardoc.xml","form_type":"4"}},{"id":2192262,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-08-08T20:33:22.000Z","date":"2022-08-04","kind":"exercise","acquired":true,"shares":531,"price":109.45,"value":58117.95,"ownership":{"direct":true},"balance_after":11840,"source":{"system":"sec-edgar","filing":"0001765581-22-000075","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000075/edgardoc.xml","form_type":"4"}},{"id":2207716,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-07-14T22:15:18.000Z","date":"2022-07-12","kind":"exercise","acquired":false,"shares":532,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":10625,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":532},"source":{"system":"sec-edgar","filing":"0001765581-22-000071","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000071/edgardoc.xml","form_type":"4"}},{"id":2207715,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-07-14T22:15:18.000Z","date":"2022-07-12","kind":"sale","acquired":false,"shares":532,"price":155,"value":82460.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000071/edgardoc.xml","form_type":"4"}},{"id":2207714,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-07-14T22:15:18.000Z","date":"2022-07-12","kind":"exercise","acquired":true,"shares":532,"price":109.45,"value":58227.4,"ownership":{"direct":true},"balance_after":11841,"source":{"system":"sec-edgar","filing":"0001765581-22-000071","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000071/edgardoc.xml","form_type":"4"}},{"id":2219629,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-29T21:55:56.000Z","date":"2022-06-27","kind":"exercise","acquired":false,"shares":8508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options were granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020,  1/4th vested on the first anniversary of the vesting commencement date and the remainder vests in 36 equal monthly installments thereafter."}],"balance_after":11157,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":8508},"source":{"system":"sec-edgar","filing":"0001765581-22-000065","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000065/edgardoc.xml","form_type":"4"}},{"id":2219628,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-06-29T21:55:56.000Z","date":"2022-06-27","kind":"sale","acquired":false,"shares":8508,"price":155,"value":1318740.0,"ownership":{"direct":true},"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000065/edgardoc.xml","form_type":"4"}},{"id":2219627,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-06-29T21:55:56.000Z","date":"2022-06-27","kind":"exercise","acquired":true,"shares":8508,"price":109.45,"value":931200.6,"ownership":{"direct":true},"balance_after":19817,"source":{"system":"sec-edgar","filing":"0001765581-22-000065","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000065/edgardoc.xml","form_type":"4"}},{"id":2236772,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-10T21:24:01.000Z","date":"2022-06-08","kind":"exercise","acquired":false,"shares":5835,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":19665,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":5835},"source":{"system":"sec-edgar","filing":"0001765581-22-000063","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000063/edgardoc.xml","form_type":"4"}},{"id":2236771,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-06-10T21:24:01.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":2652,"price":155,"value":411060.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":11309,"source":{"system":"sec-edgar","filing":"0001765581-22-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000063/edgardoc.xml","form_type":"4"}},{"id":2236770,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-06-10T21:24:01.000Z","date":"2022-06-08","kind":"sale","acquired":false,"shares":5835,"price":155,"value":904425.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":13961,"source":{"system":"sec-edgar","filing":"0001765581-22-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000063/edgardoc.xml","form_type":"4"}},{"id":2236769,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Head of Europe & Internat"}}],"security":"Ordinary Shares","published_at":"2022-06-10T21:24:01.000Z","date":"2022-06-08","kind":"exercise","acquired":true,"shares":5835,"price":109.45,"value":638640.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person."}],"balance_after":19796,"source":{"system":"sec-edgar","filing":"0001765581-22-000063","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000063/edgardoc.xml","form_type":"4"}},{"id":2342901,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Head of Europe & Interna"}}],"security":"Ordinary Shares","published_at":"2022-03-09T23:04:03.000Z","date":"2022-03-05","kind":"tax_withholding","acquired":false,"shares":1836,"price":153.96,"value":282670.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":13961,"source":{"system":"sec-edgar","filing":"0001765581-22-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000026/edgardoc.xml","form_type":"4"}},{"id":2342900,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Head of Europe & Interna"}}],"security":"Ordinary Shares","published_at":"2022-03-09T23:04:03.000Z","date":"2022-03-03","kind":"grant","acquired":true,"shares":3839,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2022, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":15797,"source":{"system":"sec-edgar","filing":"0001765581-22-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558122000026/edgardoc.xml","form_type":"4"}},{"id":2801505,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Head of Europe & Intl"}}],"security":"Ordinary Shares","published_at":"2021-03-10T00:33:55.000Z","date":"2021-03-05","kind":"tax_withholding","acquired":false,"shares":1402,"price":164.75,"value":230979.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units."}],"balance_after":11958,"source":{"system":"sec-edgar","filing":"0001765581-21-000040","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558121000040/edgardoc.xml","form_type":"4"}},{"id":2827827,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP,  Head of Europe & Intl"}}],"security":"Ordinary Shares","published_at":"2021-03-01T23:14:23.000Z","date":"2021-02-25","kind":"grant","acquired":true,"shares":3160,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2021, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":13360,"source":{"system":"sec-edgar","filing":"0001765581-21-000026","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558121000026/edgardoc.xml","form_type":"4"}},{"id":3155190,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Europe and Rest of World"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-05-11T21:03:02.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":25500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of March 2, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter."}],"balance_after":25500,"derivative":{"exercise_price":109.45,"expiration_date":"2030-05-06","underlying":"Ordinary Shares","underlying_shares":25500},"source":{"system":"sec-edgar","filing":"0001765581-20-000051","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558120000051/edgardoc.xml","form_type":"4"}},{"id":3155189,"issuer":{"id":818,"kind":"organization","name":"Jazz Pharmaceuticals plc","symbol":"JAZZ"},"owners":[{"id":25585,"kind":"person","name":"Pearce Samantha","position":1,"cik":"0001805688","reported_name":"Pearce Samantha","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Europe and Rest of World"}}],"security":"Ordinary Shares","published_at":"2020-05-11T21:03:02.000Z","date":"2020-05-07","kind":"grant","acquired":true,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years."}],"balance_after":10200,"source":{"system":"sec-edgar","filing":"0001765581-20-000051","document":"edgardoc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1805688/000176558120000051/edgardoc.xml","form_type":"4"}}]}